Forensic Analysis · Aerospace & Defense · as of Nov 8, 2026
Arxis, Inc. (ARXS)
A forensic read on Arxis, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
C · Mixed — selective
Forensic grade
2
Forensic signals
114.1%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Arxis, Inc. earns a C (Mixed — selective) forensic quality grade. 2 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
3.4%
FY2025
Return on invested capital.Return on invested capital is 3.4% in the latest fiscal year, against 1.4% in FY2024. After-tax operating profit was $81M in FY2024 and $204M in FY2025, with operating income at 13.8% of revenue in FY2024 and 17.4% in FY2025. The capital base behind it went from $6.0B in FY2024 to $6.0B in FY2025 (+1%), while the revenue it carried went from $743M to $1.6B. FY2024's operating profit carried a $13M restructuring charge that alone took about 0.2 points off that year's return, so about 0.2 of the 2.0-point rise across FY2024–FY2025 is that charge leaving the base year rather than the capital earning more.
175% of FCF
FY2025
Shareholder returns.Returned $366M to shareholders (buybacks + dividends) in FY2025 — 175% of free cash flow. That is $157M (75%) more than free cash flow covered, and more than operating cash flow as well. Total debt rose $93M over FY2025, while cash rose $139M, so the borrowing was kept, not spent on the gap. The FY2025 cash-flow statement filed $2.8B of debt issued against $2.7B repaid; net cash used in investing activities of $193M; net cash provided by financing activities of $78M. A payout past free cash flow draws the balance sheet down in every year it continues, which isn't sustainable indefinitely. Counting the $27M of stock-based comp paid out in shares on top of that, the combined claim on free cash flow is 188%.
Key fundamentals
Latest Revenue$1.59B
Revenue Growth YoY+114.1%
Revenue CAGR (2yr)+93.6%
Net Margin2.9%
Free Cash Flow$208.8M
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Arxis, Inc.'s actual 10-K/10-Q/8-K filings?